Computer Programs with Technical Effect such as enhancing speed and efficiency are patentable, reiterates the Delhi High Court

The Delhi High Court has confirmed that computer programs with demonstrable technical effect, such as improving speed or efficiency, may be patentable under Indian law. This decision aligns Indian patent jurisprudence with international standards and clarifies the scope of Section 3(k).

Read more about Computer Programs with Technical Effect such as enhancing speed and efficiency are patentable, reiterates the Delhi High Court

Rebanta Healthcare gets hurt in fight over the mark “REBAHEAL”

The Delhi High Court has issued an interim order restraining Rebanta Healthcare from using the REBAHEAL mark following a trademark infringement suit by Dr. Reddy’s. The court found the marks identical, raising concerns of public confusion and health risks.

Read more about Rebanta Healthcare gets hurt in fight over the mark “REBAHEAL”

Evaluating Trademark Infringement: Holistic View and Goods Differentiation to Determine Likelihood of Confusion

The Gujarat High Court clarified that trademark infringement requires a holistic comparison of marks and their respective goods or services. The court found no likelihood of confusion between Unisn and Unison, highlighting the need to consider all circumstances and the anti-dissection rule in such cases.

Read more about Evaluating Trademark Infringement: Holistic View and Goods Differentiation to Determine Likelihood of Confusion

Full and Transparent Disclosure of Material Facts for Ex-parte Injunctions

The Bombay High Court vacated an ex-parte injunction in a trademark dispute due to Atyati’s suppression of material facts regarding Cognizant’s prior logo use. This decision reiterates the necessity for full and transparent disclosure in ex-parte proceedings.

Read more about Full and Transparent Disclosure of Material Facts for Ex-parte Injunctions

Clarifying Product-by-Process Patent Claims in India – West Bengal Chemicals v. GTZ

The Calcutta High Court has clarified the standards for product-by-process patent claims in India, focusing on the necessity of expert evidence in infringement cases. The decision in West Bengal Chemicals v. GTZ provides important guidance for pharmaceutical patent litigation.

Read more about Clarifying Product-by-Process Patent Claims in India – West Bengal Chemicals v. GTZ